Transplantation, Autologous
"Transplantation, Autologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of an individual's own tissue from one site to another site.
Descriptor ID |
D014182
|
MeSH Number(s) |
E04.936.664
|
Concept/Terms |
Transplantation, Autologous- Transplantation, Autologous
- Autotransplantation
- Autotransplantations
- Autografting
- Autograftings
- Autologous Transplantation
- Autologous Transplantations
- Transplantations, Autologous
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Autologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Autologous".
This graph shows the total number of publications written about "Transplantation, Autologous" by people in this website by year, and whether "Transplantation, Autologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 15 | 15 |
1995 | 0 | 12 | 12 |
1996 | 1 | 22 | 23 |
1997 | 0 | 11 | 11 |
1998 | 0 | 10 | 10 |
1999 | 1 | 16 | 17 |
2000 | 1 | 11 | 12 |
2001 | 1 | 11 | 12 |
2002 | 0 | 4 | 4 |
2003 | 1 | 10 | 11 |
2004 | 1 | 16 | 17 |
2005 | 1 | 16 | 17 |
2006 | 1 | 14 | 15 |
2007 | 1 | 22 | 23 |
2008 | 0 | 20 | 20 |
2009 | 0 | 21 | 21 |
2010 | 0 | 19 | 19 |
2011 | 1 | 23 | 24 |
2012 | 0 | 20 | 20 |
2013 | 2 | 26 | 28 |
2014 | 2 | 15 | 17 |
2015 | 4 | 19 | 23 |
2016 | 0 | 22 | 22 |
2017 | 6 | 23 | 29 |
2018 | 3 | 22 | 25 |
2019 | 2 | 24 | 26 |
2020 | 2 | 28 | 30 |
2021 | 2 | 35 | 37 |
2022 | 0 | 20 | 20 |
2023 | 0 | 26 | 26 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Autologous" by people in Profiles.
-
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. Blood Cancer J. 2024 01 10; 14(1):4.
-
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant. BMC Cancer. 2023 Dec 20; 23(1):1258.
-
Safety and efficacy of a new high-dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high-risk myeloma: Matched-pair comparisons with concurrent control cohorts. Am J Hematol. 2024 Feb; 99(2):245-253.
-
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma. Transplant Cell Ther. 2024 Feb; 30(2):203.e1-203.e9.
-
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies. Blood Cancer J. 2023 11 15; 13(1):170.
-
The Impact of Frailty on Surgical and Patient-Reported Outcomes of Autologous Breast Reconstruction. Ann Surg Oncol. 2024 01; 31(1):386-387.
-
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Blood Adv. 2023 09 12; 7(17):4748-4759.
-
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma. Transplant Cell Ther. 2023 Dec; 29(12):757-762.
-
Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion. Transplant Cell Ther. 2023 Nov; 29(11):666-673.
-
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. Transplant Cell Ther. 2023 Nov; 29(11):690-694.